TY - JOUR JF - saremjm JO - SJMR VL - 3 IS - 3 PY - 2018 Y1 - 2018/10/01 TI - Treatment of primary hydrothorax in a fetus, with intrauterine thoracentesis TT - درمان هیدروتوراکس اولیه در جنین با کمک توراکوسنتز N2 - Patient Information: Hydrothorax is a rare disorder in fetal period with the prevalence of 1 in 15,000 pregnancies referring to level 3 clinics, often caused by the accumulation of lymphatic fluid in pleura. Moderate to severe cases are associated with the high incidence of mortality and morbidity in fetal and neonatal period; in this cases, fluid depletion via thoracentesis can reduce the complications of the disease. After doing ultrasonography and screening, a 29-year-old pregnant woman at 31 weeks pregnant was referred to Sarem Hospital due to fetal hydrothorax. In ultrasonography result, the severe right-sided pleural effusion and mediastinal and heart shift to the left were reported. For the fetus, thoracentesis was performed by mother's skin ultrasound. The fluid was reaccumulated after several days. Then, amniotic sac was ruptured and with premature labor pain, caesarian section was done; a neonate was borne with hydrops. At birth, thoracentesis was performed in the neonate and the chest tube was inserted. After 10 days, the neonate was discharged with good condition. The fluid obtained from pleural aspiration was Chylous. Conclusion: Hydrothorax is a life-threatening disease in fetal period, whose subsequent complications can be prevented by the timely treatment. Thoracentesis is a standard treatment that can be associated with complications, such as preterm labor and hydrothorax relapse. SP - 185 EP - 188 AU - Saremi, A.T. AU - Mortazavi, S.M. AU - Ahmadi, H. AD - “Sarem Fertility & Infertility Research Center (SAFIR)” and “Sarem Cell Research Center (SCRC)”, Sarem Women’s Hospital, Tehran, Iran KW - Hydrothorax KW - Thoracentesis KW - Chylothorax KW - Fetus UR - http://saremjrm.com/article-1-83-en.html DO - 10.29252/sjrm.2.4.185 ER -